PROXY STATEMENT

Company

RELMADA THERAPEUTICS, INC.

Filed

April 9, 2024

Period of Report

May 24, 2024

Accession Number

0001213900-24-031600

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →